(0.06%) 5 472.35 points
(0.09%) 39 148 points
(0.35%) 17 780 points
(-0.11%) $80.74
(-3.66%) $2.66
(-0.75%) $2 313.40
(0.25%) $28.94
(3.59%) $1 021.80
(0.28%) $0.936
(0.69%) $10.68
(0.46%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States...
Stats | |
---|---|
今日成交量 | 10 137 |
平均成交量 | 33 037 |
市值 | 71.12M |
EPS | $-0.0562 ( Q4 | 2024-05-09 ) |
下一个收益日期 | ( $0 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-8.53 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00100 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-11 | Nagao Hideki | Buy | 20 000 | Stock Option (Right to Buy) |
2024-06-11 | Lemerond Nicole | Buy | 20 000 | Stock Option (Right to Buy) |
2024-06-11 | Beaver Carolyn | Buy | 20 000 | Stock Option (Right to Buy) |
2024-01-09 | Obrien Geoffrey | Buy | 84 000 | Employee Stock Option (Right to Buy) |
2024-01-09 | Matsuda Kazuko | Buy | 157 500 | Employee Stock Option (Right to Buy) |
INSIDER POWER |
---|
99.01 |
Last 93 transactions |
Buy: 5 251 551 | Sell: 1 269 768 |
音量 相关性
MediciNova Inc 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
MediciNova Inc 相关性 - 货币/商品
MediciNova Inc 财务报表
Annual | 2023 |
营收: | $1.00M |
毛利润: | $979 705 (97.97 %) |
EPS: | $-0.170 |
FY | 2023 |
营收: | $1.00M |
毛利润: | $979 705 (97.97 %) |
EPS: | $-0.170 |
FY | 2022 |
营收: | $0 |
毛利润: | $-212 426 (0.00 %) |
EPS: | $-0.290 |
FY | 2021 |
营收: | $4.04M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.207 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
MediciNova Inc
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。